

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glomerular epithelial cell development (GO:0072310) | 8.86472927 |
| 2 | glomerular basement membrane development (GO:0032836) | 7.02085503 |
| 3 | neuron cell-cell adhesion (GO:0007158) | 4.47852237 |
| 4 | sequestering of actin monomers (GO:0042989) | 4.35764725 |
| 5 | retinal ganglion cell axon guidance (GO:0031290) | 4.32983778 |
| 6 | neuron recognition (GO:0008038) | 4.27949000 |
| 7 | behavioral response to nicotine (GO:0035095) | 4.25407716 |
| 8 | limb bud formation (GO:0060174) | 4.21410498 |
| 9 | establishment of mitochondrion localization (GO:0051654) | 4.16873400 |
| 10 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.08930963 |
| 11 | vocalization behavior (GO:0071625) | 4.05913840 |
| 12 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.99683651 |
| 13 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.92476656 |
| 14 | locomotory exploration behavior (GO:0035641) | 3.89980409 |
| 15 | axonal fasciculation (GO:0007413) | 3.87914469 |
| 16 | regulation of axon extension involved in axon guidance (GO:0048841) | 3.79089937 |
| 17 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.79020903 |
| 18 | dopaminergic neuron differentiation (GO:0071542) | 3.76871010 |
| 19 | synaptic vesicle maturation (GO:0016188) | 3.71793767 |
| 20 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.63189106 |
| 21 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.62416392 |
| 22 | * glomerulus development (GO:0032835) | 3.61814819 |
| 23 | * regulation of axon guidance (GO:1902667) | 3.57532063 |
| 24 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.55149134 |
| 25 | mitochondrion transport along microtubule (GO:0047497) | 3.55149134 |
| 26 | * epithelial cell differentiation involved in kidney development (GO:0035850) | 3.46785120 |
| 27 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.46777325 |
| 28 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.42589265 |
| 29 | dendrite morphogenesis (GO:0048813) | 3.41989664 |
| 30 | central nervous system neuron axonogenesis (GO:0021955) | 3.40228153 |
| 31 | protein localization to synapse (GO:0035418) | 3.39777988 |
| 32 | mechanosensory behavior (GO:0007638) | 3.31085937 |
| 33 | exploration behavior (GO:0035640) | 3.29535838 |
| 34 | glutamate receptor signaling pathway (GO:0007215) | 3.29408217 |
| 35 | hindbrain development (GO:0030902) | 3.29168755 |
| 36 | adult walking behavior (GO:0007628) | 3.27891782 |
| 37 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.27465750 |
| 38 | epithelial cilium movement (GO:0003351) | 3.23869312 |
| 39 | dendritic spine morphogenesis (GO:0060997) | 3.23359405 |
| 40 | synaptic transmission, glutamatergic (GO:0035249) | 3.20773436 |
| 41 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.20656593 |
| 42 | startle response (GO:0001964) | 3.19597208 |
| 43 | nucleobase catabolic process (GO:0046113) | 3.14193347 |
| 44 | postsynaptic membrane organization (GO:0001941) | 3.12293202 |
| 45 | protein localization to cilium (GO:0061512) | 3.10751184 |
| 46 | neuron remodeling (GO:0016322) | 3.10149037 |
| 47 | positive regulation of gastrulation (GO:2000543) | 3.09566303 |
| 48 | synaptic vesicle exocytosis (GO:0016079) | 3.05236385 |
| 49 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.04969027 |
| 50 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 3.03830557 |
| 51 | ganglion development (GO:0061548) | 3.02546575 |
| 52 | negative regulation of dendrite development (GO:2000171) | 3.02064423 |
| 53 | layer formation in cerebral cortex (GO:0021819) | 2.99954348 |
| 54 | response to auditory stimulus (GO:0010996) | 2.98972365 |
| 55 | neural tube formation (GO:0001841) | 2.97584904 |
| 56 | neuron fate determination (GO:0048664) | 2.97499784 |
| 57 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.96790461 |
| 58 | glycosphingolipid biosynthetic process (GO:0006688) | 2.95717377 |
| 59 | neurofilament cytoskeleton organization (GO:0060052) | 2.94470154 |
| 60 | * negative regulation of axon guidance (GO:1902668) | 2.92007328 |
| 61 | * negative regulation of axonogenesis (GO:0050771) | 2.91633230 |
| 62 | axon extension (GO:0048675) | 2.91516316 |
| 63 | neuron migration (GO:0001764) | 2.91420463 |
| 64 | auditory behavior (GO:0031223) | 2.91004116 |
| 65 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.89989552 |
| 66 | regulation of synapse structural plasticity (GO:0051823) | 2.89747576 |
| 67 | somite development (GO:0061053) | 2.89204578 |
| 68 | short-term memory (GO:0007614) | 2.89142243 |
| 69 | axonogenesis (GO:0007409) | 2.87144471 |
| 70 | regulation of extent of cell growth (GO:0061387) | 2.86831742 |
| 71 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.86714289 |
| 72 | neuronal action potential (GO:0019228) | 2.86353377 |
| 73 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.84597724 |
| 74 | clathrin coat assembly (GO:0048268) | 2.82114802 |
| 75 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.81275988 |
| 76 | behavioral response to ethanol (GO:0048149) | 2.80470042 |
| 77 | spinal cord development (GO:0021510) | 2.79638461 |
| 78 | synaptic vesicle endocytosis (GO:0048488) | 2.77650283 |
| 79 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.77602083 |
| 80 | neuronal action potential propagation (GO:0019227) | 2.77482817 |
| 81 | neuron-neuron synaptic transmission (GO:0007270) | 2.77464757 |
| 82 | hippocampus development (GO:0021766) | 2.77138718 |
| 83 | olfactory bulb development (GO:0021772) | 2.76436716 |
| 84 | positive regulation of axon extension (GO:0045773) | 2.74831516 |
| 85 | positive regulation of dendritic spine development (GO:0060999) | 2.74637966 |
| 86 | cilium movement (GO:0003341) | 2.74051553 |
| 87 | positive regulation of amino acid transport (GO:0051957) | 2.73780075 |
| 88 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.72597887 |
| 89 | regulation of collateral sprouting (GO:0048670) | 2.71621599 |
| 90 | auditory receptor cell stereocilium organization (GO:0060088) | 2.69703934 |
| 91 | presynaptic membrane assembly (GO:0097105) | 2.69328743 |
| 92 | regulation of synaptic vesicle transport (GO:1902803) | 2.63621828 |
| 93 | negative regulation of axon extension (GO:0030517) | 2.63009813 |
| 94 | axon extension involved in axon guidance (GO:0048846) | 2.62150744 |
| 95 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.62150744 |
| 96 | proline transport (GO:0015824) | 2.61315597 |
| 97 | microglial cell activation (GO:0001774) | 2.58681180 |
| 98 | activated T cell proliferation (GO:0050798) | 2.58582399 |
| 99 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.58182557 |
| 100 | dendrite development (GO:0016358) | 2.57213723 |
| 101 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.55079699 |
| 102 | glutamate secretion (GO:0014047) | 2.54841556 |
| 103 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.53289339 |
| 104 | regulation of platelet aggregation (GO:0090330) | 2.53152716 |
| 105 | transmission of nerve impulse (GO:0019226) | 2.51909781 |
| 106 | neuron projection extension (GO:1990138) | 2.48166149 |
| 107 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.48007977 |
| 108 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.47565631 |
| 109 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.47207806 |
| 110 | synapse assembly (GO:0007416) | 2.46077869 |
| 111 | mating behavior (GO:0007617) | 2.45547430 |
| 112 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.44733107 |
| 113 | positive regulation of synapse assembly (GO:0051965) | 2.43938894 |
| 114 | cell migration in hindbrain (GO:0021535) | 2.41516679 |
| 115 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.40935027 |
| 116 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.40704702 |
| 117 | neurotransmitter secretion (GO:0007269) | 2.40023013 |
| 118 | synapse organization (GO:0050808) | 2.39817954 |
| 119 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.39642743 |
| 120 | regulation of axon extension (GO:0030516) | 2.38455764 |
| 121 | semaphorin-plexin signaling pathway (GO:0071526) | 2.37068706 |
| 122 | presynaptic membrane organization (GO:0097090) | 2.36644543 |
| 123 | opioid receptor signaling pathway (GO:0038003) | 2.36473265 |
| 124 | neuromuscular process controlling balance (GO:0050885) | 2.32667276 |
| 125 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.32617774 |
| 126 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.31224296 |
| 127 | sialylation (GO:0097503) | 2.29922097 |
| 128 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.29272365 |
| 129 | regulation of synapse assembly (GO:0051963) | 2.29232527 |
| 130 | righting reflex (GO:0060013) | 2.27650401 |
| 131 | positive regulation by symbiont of host defense response (GO:0052509) | 2.27190160 |
| 132 | modulation by symbiont of host defense response (GO:0052031) | 2.27190160 |
| 133 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.27190160 |
| 134 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.27190160 |
| 135 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.27190160 |
| 136 | modulation by symbiont of host immune response (GO:0052553) | 2.27190160 |
| 137 | regulation of postsynaptic membrane potential (GO:0060078) | 2.24667057 |
| 138 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.23835488 |
| 139 | neuronal ion channel clustering (GO:0045161) | 2.23783618 |
| 140 | nerve growth factor signaling pathway (GO:0038180) | 2.22646878 |
| 141 | regulation of Rac protein signal transduction (GO:0035020) | 2.22052436 |
| 142 | gamma-aminobutyric acid transport (GO:0015812) | 2.21810956 |
| 143 | dendritic spine organization (GO:0097061) | 2.21592513 |
| 144 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.21371089 |
| 145 | glomerular visceral epithelial cell development (GO:0072015) | 10.0040925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.46880396 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.35828352 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.68383549 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.68086674 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.63901704 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.43493782 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.43493782 |
| 8 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.37279583 |
| 9 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.30337865 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.28705085 |
| 11 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.23388845 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.20846070 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.18448803 |
| 14 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.16718549 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.16577399 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.16132697 |
| 17 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.09365747 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.06603697 |
| 19 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.06252024 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.06019905 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.05866974 |
| 22 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.99194558 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.94571481 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.91594512 |
| 25 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.91285621 |
| 26 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.86478223 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.83835878 |
| 28 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.81942592 |
| 29 | VDR_22108803_ChIP-Seq_LS180_Human | 1.74337218 |
| 30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.70109817 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.66348627 |
| 32 | FUS_26573619_Chip-Seq_HEK293_Human | 1.64727289 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.64001955 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.60361570 |
| 35 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.57402553 |
| 36 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.56406853 |
| 37 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.55750927 |
| 38 | EWS_26573619_Chip-Seq_HEK293_Human | 1.51923863 |
| 39 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.50266082 |
| 40 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.49889182 |
| 41 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.48831465 |
| 42 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.47690003 |
| 43 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.42071946 |
| 44 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.41412554 |
| 45 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.41054011 |
| 46 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.40784649 |
| 47 | P300_19829295_ChIP-Seq_ESCs_Human | 1.40084147 |
| 48 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.38931917 |
| 49 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.38466502 |
| 50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37641945 |
| 51 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36782693 |
| 52 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36540370 |
| 53 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.36370761 |
| 54 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.36345185 |
| 55 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.35680803 |
| 56 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34872237 |
| 57 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.34866025 |
| 58 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.33066861 |
| 59 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.32212927 |
| 60 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.31169626 |
| 61 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.31105746 |
| 62 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.30688702 |
| 63 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.28783715 |
| 64 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.28370676 |
| 65 | AR_25329375_ChIP-Seq_VCAP_Human | 1.28204051 |
| 66 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.27234426 |
| 67 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27172444 |
| 68 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26252893 |
| 69 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25965579 |
| 70 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.25919603 |
| 71 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.25564209 |
| 72 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.25391595 |
| 73 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24779786 |
| 74 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.24625509 |
| 75 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.23713550 |
| 76 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.23700050 |
| 77 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.20956983 |
| 78 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20682762 |
| 79 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.17163502 |
| 80 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.17162961 |
| 81 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15853541 |
| 82 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.15486569 |
| 83 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.15126565 |
| 84 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.15126565 |
| 85 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.13653422 |
| 86 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12120310 |
| 87 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11416436 |
| 88 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11373592 |
| 89 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.11217438 |
| 90 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.10026183 |
| 91 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.09504091 |
| 92 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.09317703 |
| 93 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.08924296 |
| 94 | STAT3_23295773_ChIP-Seq_U87_Human | 1.07462394 |
| 95 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.07071996 |
| 96 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.06846840 |
| 97 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05992018 |
| 98 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05506925 |
| 99 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.05383389 |
| 100 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04813757 |
| 101 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03953650 |
| 102 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.03623178 |
| 103 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02859681 |
| 104 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02670139 |
| 105 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.02015204 |
| 106 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.97894781 |
| 107 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96993777 |
| 108 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96789858 |
| 109 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96327742 |
| 110 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96327742 |
| 111 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.95898374 |
| 112 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.94635740 |
| 113 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94059552 |
| 114 | TCF4_23295773_ChIP-Seq_U87_Human | 0.93597220 |
| 115 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.92609822 |
| 116 | AR_19668381_ChIP-Seq_PC3_Human | 0.92566911 |
| 117 | KDM2B_26808549_Chip-Seq_REH_Human | 0.91345435 |
| 118 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.91166542 |
| 119 | JUN_21703547_ChIP-Seq_K562_Human | 0.91144672 |
| 120 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90598230 |
| 121 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90595319 |
| 122 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.90587123 |
| 123 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90452331 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.26786919 |
| 2 | MP0003880_abnormal_central_pattern | 4.63174902 |
| 3 | MP0002822_catalepsy | 4.36597167 |
| 4 | MP0005423_abnormal_somatic_nervous | 3.61694035 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.25983112 |
| 6 | MP0000569_abnormal_digit_pigmentation | 3.22951341 |
| 7 | MP0002102_abnormal_ear_morphology | 3.09707375 |
| 8 | MP0002063_abnormal_learning/memory/cond | 2.90935142 |
| 9 | MP0004270_analgesia | 2.56793734 |
| 10 | MP0001486_abnormal_startle_reflex | 2.55986103 |
| 11 | * MP0009745_abnormal_behavioral_response | 2.51600705 |
| 12 | MP0006276_abnormal_autonomic_nervous | 2.50605679 |
| 13 | MP0000778_abnormal_nervous_system | 2.49544877 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.48015137 |
| 15 | * MP0002064_seizures | 2.37619938 |
| 16 | MP0010386_abnormal_urinary_bladder | 2.25868002 |
| 17 | MP0001968_abnormal_touch/_nociception | 2.19274485 |
| 18 | MP0003303_peritoneal_inflammation | 2.13071979 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.12962872 |
| 20 | MP0000566_synostosis | 2.11702203 |
| 21 | MP0009046_muscle_twitch | 2.07294522 |
| 22 | MP0003283_abnormal_digestive_organ | 2.07015127 |
| 23 | MP0005623_abnormal_meninges_morphology | 2.04012468 |
| 24 | MP0002734_abnormal_mechanical_nocicepti | 2.03457286 |
| 25 | MP0001440_abnormal_grooming_behavior | 1.94061577 |
| 26 | MP0003690_abnormal_glial_cell | 1.86183204 |
| 27 | MP0002184_abnormal_innervation | 1.80340308 |
| 28 | MP0003121_genomic_imprinting | 1.79982298 |
| 29 | MP0001501_abnormal_sleep_pattern | 1.76566780 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.72169912 |
| 31 | MP0001986_abnormal_taste_sensitivity | 1.72059454 |
| 32 | MP0002272_abnormal_nervous_system | 1.68677887 |
| 33 | MP0005645_abnormal_hypothalamus_physiol | 1.68227853 |
| 34 | MP0003890_abnormal_embryonic-extraembry | 1.67322511 |
| 35 | MP0002751_abnormal_autonomic_nervous | 1.65025416 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.62803906 |
| 37 | MP0002067_abnormal_sensory_capabilities | 1.62750250 |
| 38 | MP0002733_abnormal_thermal_nociception | 1.62465867 |
| 39 | MP0009780_abnormal_chondrocyte_physiolo | 1.60896229 |
| 40 | MP0001905_abnormal_dopamine_level | 1.60564872 |
| 41 | MP0004858_abnormal_nervous_system | 1.58596005 |
| 42 | MP0003787_abnormal_imprinting | 1.58132744 |
| 43 | MP0002736_abnormal_nociception_after | 1.56331453 |
| 44 | MP0001529_abnormal_vocalization | 1.55570695 |
| 45 | MP0005499_abnormal_olfactory_system | 1.52354071 |
| 46 | MP0005394_taste/olfaction_phenotype | 1.52354071 |
| 47 | MP0002234_abnormal_pharynx_morphology | 1.48275420 |
| 48 | MP0000920_abnormal_myelination | 1.47809290 |
| 49 | MP0002653_abnormal_ependyma_morphology | 1.47682642 |
| 50 | MP0001970_abnormal_pain_threshold | 1.47362199 |
| 51 | MP0002909_abnormal_adrenal_gland | 1.43648241 |
| 52 | MP0004133_heterotaxia | 1.42412862 |
| 53 | MP0004811_abnormal_neuron_physiology | 1.41670337 |
| 54 | MP0003329_amyloid_beta_deposits | 1.39410215 |
| 55 | MP0005386_behavior/neurological_phenoty | 1.39218401 |
| 56 | MP0004924_abnormal_behavior | 1.39218401 |
| 57 | MP0003634_abnormal_glial_cell | 1.38713502 |
| 58 | MP0002882_abnormal_neuron_morphology | 1.35136527 |
| 59 | MP0004742_abnormal_vestibular_system | 1.32923245 |
| 60 | MP0006082_CNS_inflammation | 1.32521334 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.29044751 |
| 62 | MP0000955_abnormal_spinal_cord | 1.24576971 |
| 63 | MP0005646_abnormal_pituitary_gland | 1.21599840 |
| 64 | MP0002066_abnormal_motor_capabilities/c | 1.21456052 |
| 65 | MP0005253_abnormal_eye_physiology | 1.16065309 |
| 66 | MP0001502_abnormal_circadian_rhythm | 1.15294830 |
| 67 | MP0001963_abnormal_hearing_physiology | 1.14674427 |
| 68 | MP0002152_abnormal_brain_morphology | 1.11028807 |
| 69 | MP0008789_abnormal_olfactory_epithelium | 1.10630383 |
| 70 | MP0000604_amyloidosis | 1.09673948 |
| 71 | MP0002090_abnormal_vision | 1.08288021 |
| 72 | MP0008961_abnormal_basal_metabolism | 1.06557316 |
| 73 | MP0005197_abnormal_uvea_morphology | 1.05624640 |
| 74 | MP0000230_abnormal_systemic_arterial | 1.00956903 |
| 75 | MP0006072_abnormal_retinal_apoptosis | 1.00458839 |
| 76 | MP0004510_myositis | 0.99800671 |
| 77 | MP0008569_lethality_at_weaning | 0.98550858 |
| 78 | MP0002928_abnormal_bile_duct | 0.98223836 |
| 79 | MP0004885_abnormal_endolymph | 0.97459093 |
| 80 | MP0005058_abnormal_lysosome_morphology | 0.96868302 |
| 81 | MP0003879_abnormal_hair_cell | 0.95855394 |
| 82 | MP0002638_abnormal_pupillary_reflex | 0.94918587 |
| 83 | MP0001485_abnormal_pinna_reflex | 0.94887003 |
| 84 | MP0002938_white_spotting | 0.94460836 |
| 85 | MP0003011_delayed_dark_adaptation | 0.93054832 |
| 86 | MP0003136_yellow_coat_color | 0.91366595 |
| 87 | MP0002752_abnormal_somatic_nervous | 0.91036602 |
| 88 | MP0006292_abnormal_olfactory_placode | 0.87869378 |
| 89 | MP0008877_abnormal_DNA_methylation | 0.87617100 |
| 90 | MP0002229_neurodegeneration | 0.86738199 |
| 91 | MP0002282_abnormal_trachea_morphology | 0.86405927 |
| 92 | MP0005551_abnormal_eye_electrophysiolog | 0.84915352 |
| 93 | MP0005391_vision/eye_phenotype | 0.83386503 |
| 94 | MP0005409_darkened_coat_color | 0.82978229 |
| 95 | MP0003119_abnormal_digestive_system | 0.82444248 |
| 96 | MP0003633_abnormal_nervous_system | 0.79445698 |
| 97 | MP0000049_abnormal_middle_ear | 0.78374548 |
| 98 | MP0003075_altered_response_to | 0.77979756 |
| 99 | MP0002069_abnormal_eating/drinking_beha | 0.77867401 |
| 100 | MP0003315_abnormal_perineum_morphology | 0.77583794 |
| 101 | MP0001984_abnormal_olfaction | 0.77570615 |
| 102 | MP0000026_abnormal_inner_ear | 0.76932734 |
| 103 | MP0005167_abnormal_blood-brain_barrier | 0.76902343 |
| 104 | MP0004142_abnormal_muscle_tone | 0.76686999 |
| 105 | MP0001188_hyperpigmentation | 0.76535851 |
| 106 | MP0002998_abnormal_bone_remodeling | 0.75513481 |
| 107 | MP0001293_anophthalmia | 0.74242303 |
| 108 | MP0005084_abnormal_gallbladder_morpholo | 0.73129142 |
| 109 | MP0000015_abnormal_ear_pigmentation | 0.72212176 |
| 110 | MP0005195_abnormal_posterior_eye | 0.71987022 |
| 111 | MP0004272_abnormal_basement_membrane | 0.71922022 |
| 112 | MP0003631_nervous_system_phenotype | 0.71568634 |
| 113 | MP0001879_abnormal_lymphatic_vessel | 0.70904119 |
| 114 | MP0003632_abnormal_nervous_system | 0.66297285 |
| 115 | MP0004145_abnormal_muscle_electrophysio | 0.65729860 |
| 116 | MP0005310_abnormal_salivary_gland | 0.65276977 |
| 117 | MP0003942_abnormal_urinary_system | 0.64602460 |
| 118 | MP0001835_abnormal_antigen_presentation | 0.63979972 |
| 119 | MP0001324_abnormal_eye_pigmentation | 0.63704330 |
| 120 | MP0004134_abnormal_chest_morphology | 0.63178516 |
| 121 | MP0001299_abnormal_eye_distance/ | 0.62066664 |
| 122 | MP0004084_abnormal_cardiac_muscle | 0.61866366 |
| 123 | MP0003861_abnormal_nervous_system | 0.60488899 |
| 124 | MP0003122_maternal_imprinting | 0.59371609 |
| 125 | MP0000538_abnormal_urinary_bladder | 0.58901494 |
| 126 | MP0000534_abnormal_ureter_morphology | 0.58610144 |
| 127 | MP0004085_abnormal_heartbeat | 0.58369240 |
| 128 | MP0000631_abnormal_neuroendocrine_gland | 0.58312208 |
| 129 | MP0002277_abnormal_respiratory_mucosa | 0.57209498 |
| 130 | MP0005187_abnormal_penis_morphology | 0.56727609 |
| 131 | MP0003938_abnormal_ear_development | 0.54668718 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mesangial abnormality (HP:0001966) | 4.94884033 |
| 2 | Glomerulonephritis (HP:0000099) | 4.92174494 |
| 3 | * Focal segmental glomerulosclerosis (HP:0000097) | 4.20530921 |
| 4 | Focal motor seizures (HP:0011153) | 4.14496813 |
| 5 | Cortical dysplasia (HP:0002539) | 4.14401502 |
| 6 | Mutism (HP:0002300) | 4.07750232 |
| 7 | Nephritis (HP:0000123) | 3.86328233 |
| 8 | Neurofibrillary tangles (HP:0002185) | 3.74527177 |
| 9 | True hermaphroditism (HP:0010459) | 3.68320920 |
| 10 | Supranuclear gaze palsy (HP:0000605) | 3.63902787 |
| 11 | Pancreatic fibrosis (HP:0100732) | 3.37427272 |
| 12 | Stage 5 chronic kidney disease (HP:0003774) | 3.34028013 |
| 13 | Focal seizures (HP:0007359) | 3.33109894 |
| 14 | Inappropriate behavior (HP:0000719) | 3.30980032 |
| 15 | Recurrent abscess formation (HP:0002722) | 3.30373693 |
| 16 | Myokymia (HP:0002411) | 3.27758245 |
| 17 | * Hypoalbuminemia (HP:0003073) | 3.27118446 |
| 18 | * Abnormal albumin level (HP:0012116) | 3.27118446 |
| 19 | Pancreatic cysts (HP:0001737) | 3.26491607 |
| 20 | Gait imbalance (HP:0002141) | 3.16867756 |
| 21 | Abnormal ciliary motility (HP:0012262) | 3.16256579 |
| 22 | Abnormality of the labia minora (HP:0012880) | 3.09618064 |
| 23 | Agitation (HP:0000713) | 3.07916659 |
| 24 | Disinhibition (HP:0000734) | 3.03281924 |
| 25 | Febrile seizures (HP:0002373) | 3.02284830 |
| 26 | Cerebral inclusion bodies (HP:0100314) | 3.02085589 |
| 27 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.01530315 |
| 28 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.01530315 |
| 29 | Polyphagia (HP:0002591) | 2.99150627 |
| 30 | Rapidly progressive (HP:0003678) | 2.95805444 |
| 31 | Retinal dysplasia (HP:0007973) | 2.95228222 |
| 32 | Epileptic encephalopathy (HP:0200134) | 2.93697170 |
| 33 | * Glomerulosclerosis (HP:0000096) | 2.89189626 |
| 34 | Abnormality of midbrain morphology (HP:0002418) | 2.86079450 |
| 35 | Molar tooth sign on MRI (HP:0002419) | 2.86079450 |
| 36 | Excessive salivation (HP:0003781) | 2.84122184 |
| 37 | Drooling (HP:0002307) | 2.84122184 |
| 38 | Specific learning disability (HP:0001328) | 2.81779084 |
| 39 | Nephronophthisis (HP:0000090) | 2.78866131 |
| 40 | * Nephrotic syndrome (HP:0000100) | 2.78431302 |
| 41 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.75627616 |
| 42 | Medial flaring of the eyebrow (HP:0010747) | 2.73874163 |
| 43 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.73614428 |
| 44 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.73229598 |
| 45 | Exotropia (HP:0000577) | 2.68142084 |
| 46 | Esotropia (HP:0000565) | 2.64425119 |
| 47 | Blue irides (HP:0000635) | 2.63176878 |
| 48 | Tubular atrophy (HP:0000092) | 2.61707849 |
| 49 | Visual hallucinations (HP:0002367) | 2.61635000 |
| 50 | Congenital primary aphakia (HP:0007707) | 2.60151424 |
| 51 | Limb dystonia (HP:0002451) | 2.58558292 |
| 52 | Atonic seizures (HP:0010819) | 2.50718610 |
| 53 | Genital tract atresia (HP:0001827) | 2.49906554 |
| 54 | Nephrogenic diabetes insipidus (HP:0009806) | 2.48264738 |
| 55 | Progressive cerebellar ataxia (HP:0002073) | 2.47724192 |
| 56 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.46369706 |
| 57 | Progressive inability to walk (HP:0002505) | 2.45866402 |
| 58 | Vaginal atresia (HP:0000148) | 2.43488902 |
| 59 | Neonatal respiratory distress (HP:0002643) | 2.43339532 |
| 60 | Recurrent bacterial skin infections (HP:0005406) | 2.43026011 |
| 61 | Abnormality of salivation (HP:0100755) | 2.39152469 |
| 62 | Broad-based gait (HP:0002136) | 2.37403232 |
| 63 | Cystic liver disease (HP:0006706) | 2.37049599 |
| 64 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.35704953 |
| 65 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.35704953 |
| 66 | Spastic tetraplegia (HP:0002510) | 2.34938730 |
| 67 | Urinary urgency (HP:0000012) | 2.34835085 |
| 68 | Genetic anticipation (HP:0003743) | 2.33712384 |
| 69 | Neoplasm of the adrenal cortex (HP:0100641) | 2.32661129 |
| 70 | Apathy (HP:0000741) | 2.30866747 |
| 71 | Retinal atrophy (HP:0001105) | 2.29593842 |
| 72 | High anterior hairline (HP:0009890) | 2.28554753 |
| 73 | Hypsarrhythmia (HP:0002521) | 2.28504953 |
| 74 | Ankle clonus (HP:0011448) | 2.27366965 |
| 75 | Type II lissencephaly (HP:0007260) | 2.26724107 |
| 76 | Papilledema (HP:0001085) | 2.26250077 |
| 77 | Amblyopia (HP:0000646) | 2.25310353 |
| 78 | Abnormality of the renal medulla (HP:0100957) | 2.24342822 |
| 79 | Absent speech (HP:0001344) | 2.23675861 |
| 80 | Action tremor (HP:0002345) | 2.23656761 |
| 81 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.22849899 |
| 82 | Epileptiform EEG discharges (HP:0011182) | 2.22807694 |
| 83 | EEG with generalized epileptiform discharges (HP:0011198) | 2.21088544 |
| 84 | Anencephaly (HP:0002323) | 2.18585241 |
| 85 | Metaphyseal dysplasia (HP:0100255) | 2.17600534 |
| 86 | Abnormal eating behavior (HP:0100738) | 2.17439933 |
| 87 | Pendular nystagmus (HP:0012043) | 2.17339527 |
| 88 | Akinesia (HP:0002304) | 2.17209210 |
| 89 | Abnormality of the corticospinal tract (HP:0002492) | 2.16959873 |
| 90 | Nonprogressive disorder (HP:0003680) | 2.16931427 |
| 91 | Intellectual disability, moderate (HP:0002342) | 2.16072643 |
| 92 | Generalized tonic-clonic seizures (HP:0002069) | 2.13439841 |
| 93 | Anophthalmia (HP:0000528) | 2.13097651 |
| 94 | Hepatoblastoma (HP:0002884) | 2.12899843 |
| 95 | Absence seizures (HP:0002121) | 2.11630313 |
| 96 | Hypoplasia of the corpus callosum (HP:0002079) | 2.11434951 |
| 97 | Abnormal large intestine physiology (HP:0012700) | 2.11207762 |
| 98 | Bowel incontinence (HP:0002607) | 2.11150267 |
| 99 | Chronic hepatic failure (HP:0100626) | 2.08280921 |
| 100 | Narrow forehead (HP:0000341) | 2.06666385 |
| 101 | Abnormality of glycolipid metabolism (HP:0010969) | 2.06583006 |
| 102 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.06583006 |
| 103 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.06583006 |
| 104 | Protruding tongue (HP:0010808) | 2.06034930 |
| 105 | Hyperthyroidism (HP:0000836) | 2.04658466 |
| 106 | Hypoplasia of the brainstem (HP:0002365) | 2.04507640 |
| 107 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.04507640 |
| 108 | Failure to thrive in infancy (HP:0001531) | 2.03926497 |
| 109 | Oligodactyly (hands) (HP:0001180) | 2.03910035 |
| 110 | Diminished motivation (HP:0000745) | 2.02959463 |
| 111 | Abnormality of the lower motor neuron (HP:0002366) | 2.02398499 |
| 112 | Neuronal loss in central nervous system (HP:0002529) | 2.01774401 |
| 113 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.01709058 |
| 114 | Rhinitis (HP:0012384) | 2.01638349 |
| 115 | Anomalous pulmonary venous return (HP:0010772) | 2.00851850 |
| 116 | Increased cerebral lipofuscin (HP:0011813) | 1.99811446 |
| 117 | Hyperventilation (HP:0002883) | 1.98964404 |
| 118 | Optic nerve hypoplasia (HP:0000609) | 1.98742181 |
| 119 | Systemic lupus erythematosus (HP:0002725) | 1.98145147 |
| 120 | Increased circulating renin level (HP:0000848) | 1.98141158 |
| 121 | Sclerocornea (HP:0000647) | 1.97873941 |
| 122 | Ulnar claw (HP:0001178) | 1.96927502 |
| 123 | Dialeptic seizures (HP:0011146) | 1.96553169 |
| 124 | Corneal erosion (HP:0200020) | 1.96042066 |
| 125 | Spastic gait (HP:0002064) | 1.94933100 |
| 126 | Stomach cancer (HP:0012126) | 1.91680629 |
| 127 | Lissencephaly (HP:0001339) | 1.91159294 |
| 128 | Lymphangioma (HP:0100764) | 1.88067957 |
| 129 | Fetal akinesia sequence (HP:0001989) | 1.86017367 |
| 130 | Abnormality of binocular vision (HP:0011514) | 1.83804375 |
| 131 | Diplopia (HP:0000651) | 1.83804375 |
| 132 | Pheochromocytoma (HP:0002666) | 1.83557349 |
| 133 | Polymicrogyria (HP:0002126) | 1.83471527 |
| 134 | Intellectual disability, severe (HP:0010864) | 1.83177131 |
| 135 | * Proteinuria (HP:0000093) | 1.82626814 |
| 136 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.82183815 |
| 137 | Congenital hepatic fibrosis (HP:0002612) | 1.82173202 |
| 138 | Hypothermia (HP:0002045) | 1.82165100 |
| 139 | Atelectasis (HP:0100750) | 1.82005466 |
| 140 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.80996187 |
| 141 | Absent/shortened dynein arms (HP:0200106) | 1.80996187 |
| 142 | Obstructive lung disease (HP:0006536) | 1.79866206 |
| 143 | Chronic obstructive pulmonary disease (HP:0006510) | 1.79866206 |
| 144 | Generalized myoclonic seizures (HP:0002123) | 1.79487737 |
| 145 | Hypoproteinemia (HP:0003075) | 1.79418400 |
| 146 | Concave nail (HP:0001598) | 1.79238082 |
| 147 | Arterial tortuosity (HP:0005116) | 1.76122725 |
| 148 | Mediastinal lymphadenopathy (HP:0100721) | 1.75969123 |
| 149 | Heterochromia iridis (HP:0001100) | 1.74888150 |
| 150 | Poor eye contact (HP:0000817) | 1.74883796 |
| 151 | Dysostosis multiplex (HP:0000943) | 1.74151591 |
| 152 | Aqueductal stenosis (HP:0002410) | 1.73114765 |
| 153 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.72705759 |
| 154 | Amyotrophic lateral sclerosis (HP:0007354) | 1.71563767 |
| 155 | Inability to walk (HP:0002540) | 1.71529605 |
| 156 | Curly hair (HP:0002212) | 1.70979061 |
| 157 | Hemiparesis (HP:0001269) | 1.70887725 |
| 158 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.70843058 |
| 159 | Tented upper lip vermilion (HP:0010804) | 1.66434672 |
| 160 | Recurrent corneal erosions (HP:0000495) | 1.66305838 |
| 161 | Pachygyria (HP:0001302) | 1.65598204 |
| 162 | Anosmia (HP:0000458) | 1.63673058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 5.17987403 |
| 2 | NTRK3 | 3.36456439 |
| 3 | SIK2 | 2.76396610 |
| 4 | ICK | 2.55784077 |
| 5 | MAP3K9 | 2.25717306 |
| 6 | NTRK2 | 2.17275562 |
| 7 | SIK3 | 2.06670777 |
| 8 | OXSR1 | 2.06194821 |
| 9 | MAPK13 | 2.04527732 |
| 10 | EPHA4 | 2.03783738 |
| 11 | MAP4K2 | 2.02652339 |
| 12 | MAPK15 | 1.93176880 |
| 13 | FES | 1.92992745 |
| 14 | MINK1 | 1.92919628 |
| 15 | EPHB2 | 1.92228773 |
| 16 | MAP3K4 | 1.89233718 |
| 17 | MAP2K7 | 1.83270914 |
| 18 | CASK | 1.70900507 |
| 19 | TGFBR2 | 1.67239770 |
| 20 | PINK1 | 1.61933752 |
| 21 | PAK6 | 1.61254503 |
| 22 | GRK7 | 1.57239115 |
| 23 | RIPK4 | 1.56172358 |
| 24 | EPHA3 | 1.55628908 |
| 25 | DYRK2 | 1.54451377 |
| 26 | DYRK3 | 1.52185993 |
| 27 | STK39 | 1.49647781 |
| 28 | IRAK2 | 1.47897872 |
| 29 | TNIK | 1.45555854 |
| 30 | TYRO3 | 1.40079617 |
| 31 | PKN1 | 1.39126767 |
| 32 | NTRK1 | 1.37442610 |
| 33 | WNK4 | 1.37122891 |
| 34 | ERBB3 | 1.32586210 |
| 35 | CDK5 | 1.30461569 |
| 36 | PRPF4B | 1.26882102 |
| 37 | GRK5 | 1.21970450 |
| 38 | PHKG1 | 1.20055397 |
| 39 | PHKG2 | 1.20055397 |
| 40 | FGR | 1.19751024 |
| 41 | TRIM28 | 1.08530232 |
| 42 | KSR1 | 1.07834949 |
| 43 | CSNK1G2 | 1.02304644 |
| 44 | CDK19 | 1.02224673 |
| 45 | DYRK1B | 0.97560414 |
| 46 | CAMK1G | 0.95456459 |
| 47 | CAMK2B | 0.95169576 |
| 48 | NEK1 | 0.93816191 |
| 49 | DAPK2 | 0.93015947 |
| 50 | CSNK1A1L | 0.90552497 |
| 51 | PLK2 | 0.86361785 |
| 52 | UHMK1 | 0.83031228 |
| 53 | SGK2 | 0.81656449 |
| 54 | CCNB1 | 0.79215984 |
| 55 | PNCK | 0.79112989 |
| 56 | FRK | 0.78942433 |
| 57 | LATS2 | 0.78427664 |
| 58 | FYN | 0.78007025 |
| 59 | MAP2K4 | 0.77767593 |
| 60 | CSNK1G3 | 0.77497448 |
| 61 | DYRK1A | 0.77201561 |
| 62 | IRAK4 | 0.76184948 |
| 63 | PRKCE | 0.74444274 |
| 64 | CDK18 | 0.72628908 |
| 65 | ADRBK2 | 0.72592701 |
| 66 | CAMK4 | 0.72476175 |
| 67 | PAK3 | 0.72399496 |
| 68 | MAP3K6 | 0.72302608 |
| 69 | CAMKK1 | 0.72269943 |
| 70 | RPS6KA4 | 0.71857481 |
| 71 | CDK15 | 0.69151772 |
| 72 | CDK14 | 0.68924693 |
| 73 | CAMK1D | 0.67629520 |
| 74 | MARK2 | 0.67243344 |
| 75 | KSR2 | 0.66727047 |
| 76 | CAMK2A | 0.66426249 |
| 77 | SGK223 | 0.66339171 |
| 78 | SGK494 | 0.66339171 |
| 79 | PRKCG | 0.65191191 |
| 80 | PRKCZ | 0.63823019 |
| 81 | JAK1 | 0.61504499 |
| 82 | MAP3K12 | 0.60073888 |
| 83 | KIT | 0.59750394 |
| 84 | LATS1 | 0.58726697 |
| 85 | CSK | 0.56090240 |
| 86 | CDK11A | 0.55606862 |
| 87 | PAK4 | 0.53972600 |
| 88 | PRKCH | 0.53258653 |
| 89 | STK11 | 0.52584231 |
| 90 | IRAK1 | 0.52088661 |
| 91 | SGK1 | 0.51542697 |
| 92 | TYK2 | 0.50633707 |
| 93 | ROCK1 | 0.50302674 |
| 94 | WNK3 | 0.50158264 |
| 95 | MAP3K13 | 0.49844230 |
| 96 | CDK3 | 0.48849520 |
| 97 | CSNK1G1 | 0.47796624 |
| 98 | TIE1 | 0.47758621 |
| 99 | INSRR | 0.47621113 |
| 100 | NEK6 | 0.47133715 |
| 101 | PRKACB | 0.46598245 |
| 102 | VRK1 | 0.46492268 |
| 103 | BMPR2 | 0.46288804 |
| 104 | NEK2 | 0.45507708 |
| 105 | MAPK12 | 0.44652660 |
| 106 | CSF1R | 0.44591833 |
| 107 | BCR | 0.44373253 |
| 108 | YES1 | 0.43257388 |
| 109 | MAP3K14 | 0.42621861 |
| 110 | ERBB2 | 0.42222965 |
| 111 | BMPR1B | 0.42128657 |
| 112 | MAPK9 | 0.41534005 |
| 113 | TAOK1 | 0.41513788 |
| 114 | RET | 0.40986518 |
| 115 | PRKG1 | 0.40976315 |
| 116 | CAMKK2 | 0.40916574 |
| 117 | PDPK1 | 0.40753385 |
| 118 | RPS6KA2 | 0.40319001 |
| 119 | PDGFRB | 0.40136175 |
| 120 | EPHB1 | 0.39731809 |
| 121 | HCK | 0.38655374 |
| 122 | BLK | 0.37995113 |
| 123 | ADRBK1 | 0.37367349 |
| 124 | PRKACA | 0.37296349 |
| 125 | MAPK4 | 0.34345227 |
| 126 | MAP3K5 | 0.34121942 |
| 127 | STK38L | 0.32971304 |
| 128 | BRD4 | 0.32196099 |
| 129 | MATK | 0.29159780 |
| 130 | PRKAA1 | 0.27794223 |
| 131 | CSNK1A1 | 0.26889443 |
| 132 | CAMK1 | 0.25916416 |
| 133 | SGK3 | 0.25170104 |
| 134 | RPS6KA5 | 0.24616773 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.17799788 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.24113613 |
| 3 | Axon guidance_Homo sapiens_hsa04360 | 2.17850210 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 1.99448998 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.91849722 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 1.85551000 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.85096910 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 1.85014708 |
| 9 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.70563713 |
| 10 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.59858451 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 1.57445136 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 1.53168184 |
| 13 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.46716824 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.43733170 |
| 15 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.42174024 |
| 16 | Cocaine addiction_Homo sapiens_hsa05030 | 1.38510067 |
| 17 | Renin secretion_Homo sapiens_hsa04924 | 1.38166926 |
| 18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.37263992 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.35932760 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.35019501 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.34647676 |
| 22 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.24437497 |
| 23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.22394330 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.20871011 |
| 25 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.20689412 |
| 26 | Taste transduction_Homo sapiens_hsa04742 | 1.19434206 |
| 27 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.19300837 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.19130570 |
| 29 | Gap junction_Homo sapiens_hsa04540 | 1.18862763 |
| 30 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.18694714 |
| 31 | Alcoholism_Homo sapiens_hsa05034 | 1.17626377 |
| 32 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.17102312 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.16936878 |
| 34 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.15382731 |
| 35 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.14857067 |
| 36 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.14752438 |
| 37 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.13966696 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.12793296 |
| 39 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.11270363 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.10405344 |
| 41 | Insulin secretion_Homo sapiens_hsa04911 | 1.08085036 |
| 42 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.07456104 |
| 43 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.07063226 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.06895478 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05873636 |
| 46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.02919460 |
| 47 | Lysosome_Homo sapiens_hsa04142 | 1.00977162 |
| 48 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.99249370 |
| 49 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.99245453 |
| 50 | Glioma_Homo sapiens_hsa05214 | 0.98646103 |
| 51 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.95991933 |
| 52 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.95752574 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95702851 |
| 54 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.95184007 |
| 55 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.94672527 |
| 56 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.94652360 |
| 57 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.94542277 |
| 58 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94144997 |
| 59 | Endometrial cancer_Homo sapiens_hsa05213 | 0.92694817 |
| 60 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.91033850 |
| 61 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.89770900 |
| 62 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.87844681 |
| 63 | Parkinsons disease_Homo sapiens_hsa05012 | 0.87635508 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.87457718 |
| 65 | Tuberculosis_Homo sapiens_hsa05152 | 0.87178409 |
| 66 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.86245246 |
| 67 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.85408733 |
| 68 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.85086830 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.82808962 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.82735132 |
| 71 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.81647141 |
| 72 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.81616723 |
| 73 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.81218189 |
| 74 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.80422472 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80273074 |
| 76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79094697 |
| 77 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.78646059 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.78013494 |
| 79 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.77134820 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.77078106 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.76649673 |
| 82 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.75715006 |
| 83 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75079120 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74211785 |
| 85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73433766 |
| 86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.71652498 |
| 87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71483058 |
| 88 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.69599884 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.69530434 |
| 90 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.68288703 |
| 91 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.67973099 |
| 92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.67504631 |
| 93 | Salmonella infection_Homo sapiens_hsa05132 | 0.67003908 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66636342 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66620474 |
| 96 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66161985 |
| 97 | Phototransduction_Homo sapiens_hsa04744 | 0.65799034 |
| 98 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.65068057 |
| 99 | Other glycan degradation_Homo sapiens_hsa00511 | 0.64885637 |
| 100 | Focal adhesion_Homo sapiens_hsa04510 | 0.64597800 |
| 101 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.63894624 |
| 102 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.63136135 |
| 103 | Leishmaniasis_Homo sapiens_hsa05140 | 0.62707002 |
| 104 | Alzheimers disease_Homo sapiens_hsa05010 | 0.61876772 |
| 105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.61738339 |
| 106 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60750213 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.60737716 |
| 108 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60636514 |
| 109 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59738577 |
| 110 | Melanogenesis_Homo sapiens_hsa04916 | 0.59439582 |
| 111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59279395 |
| 112 | Pertussis_Homo sapiens_hsa05133 | 0.58889245 |
| 113 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.58781471 |
| 114 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.58483285 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58264653 |
| 116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57766330 |
| 117 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57694056 |
| 118 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57073035 |
| 119 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.56036327 |
| 120 | Viral myocarditis_Homo sapiens_hsa05416 | 0.55271772 |
| 121 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.51744156 |
| 122 | Huntingtons disease_Homo sapiens_hsa05016 | 0.46440879 |
| 123 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.45709158 |
| 124 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.44515279 |
| 125 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40605307 |
| 126 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.39868661 |
| 127 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.38175897 |
| 128 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.35045218 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30741515 |
| 130 | Basal transcription factors_Homo sapiens_hsa03022 | 0.27644593 |
| 131 | Asthma_Homo sapiens_hsa05310 | 0.27421720 |
| 132 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.25940730 |
| 133 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.24085476 |

